메뉴 건너뛰기




Volumn 66, Issue 9, 2015, Pages 856-861

Effect of a Natural Supplement Containing Curcuma Longa, Guggul, and Chlorogenic Acid in Patients with Metabolic Syndrome

Author keywords

chlorogenic acid; cholesterol; Curcuma longa; guggul; inulin; metabolic syndrome; natural supplement; oxidative stress; silymarin

Indexed keywords

ANTIDIABETIC AGENT; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; CHLOROGENIC ACID; CURCUMA LONGA EXTRACT; GLUCOSE; GLUTATHIONE; GUGGUL; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INULIN; KEPAR; LIPID; LIPID HYDROPEROXIDE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; SILYMARIN; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; CHOLESTEROL; GLUCOSE BLOOD LEVEL; GUGGULU EXTRACT; PLANT GUM;

EID: 84941116306     PISSN: 00033197     EISSN: 19401574     Source Type: Journal    
DOI: 10.1177/0003319714568792     Document Type: Article
Times cited : (39)

References (48)
  • 1
    • 42249093870 scopus 로고    scopus 로고
    • Metabolic syndrome pandemic
    • Grundy SM,. Metabolic syndrome pandemic. Arterioscler Thromb Vasc Biol. 2008; 28 (4): 629-636.
    • (2008) Arterioscler Thromb Vasc Biol , vol.28 , Issue.4 , pp. 629-636
    • Grundy, S.M.1
  • 2
    • 84883311618 scopus 로고    scopus 로고
    • Prevalence and trends of metabolic syndrome in the adult U.S. Population, 1999-2010
    • Beltran-Sanchez H, Harhay MO, Harhay MM, McElligott S,. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013; 62 (8): 697-703.
    • (2013) J Am Coll Cardiol , vol.62 , Issue.8 , pp. 697-703
    • Beltran-Sanchez, H.1    Harhay, M.O.2    Harhay, M.M.3    McElligott, S.4
  • 3
    • 81555203150 scopus 로고    scopus 로고
    • The emerging epidemic of obesity, diabetes, and the metabolic syndrome in China
    • Shen J, Goyal A, Sperling L,. The emerging epidemic of obesity, diabetes, and the metabolic syndrome in china. Cardiol Res Pract. 2012; 2012: 178675.
    • (2012) Cardiol Res Pract , vol.2012 , pp. 178675
    • Shen, J.1    Goyal, A.2    Sperling, L.3
  • 4
    • 84928027364 scopus 로고    scopus 로고
    • Nutraceuticals in lipid-lowering treatment: A narrative review on the role of Chitosan
    • Patti AM, Katsiki N, Nikolic D, Al-Rasadi K, Rizzo M,. Nutraceuticals in lipid-lowering treatment: a narrative review on the role of Chitosan. Angiology. 2015; 66 (5): 416-421.
    • (2015) Angiology , vol.66 , Issue.5 , pp. 416-421
    • Patti, A.M.1    Katsiki, N.2    Nikolic, D.3    Al-Rasadi, K.4    Rizzo, M.5
  • 5
    • 84923032252 scopus 로고    scopus 로고
    • Association between flavonoid-rich fruit and vegetable consumption and total serum
    • Loprinzi PD, Mahoney SE,. Association between flavonoid-rich fruit and vegetable consumption and total serum. Angiology. 2015; 66 (3): 286-290.
    • (2015) Angiology , vol.66 , Issue.3 , pp. 286-290
    • Loprinzi, P.D.1    Mahoney, S.E.2
  • 6
    • 72249115973 scopus 로고    scopus 로고
    • Dietary fiber supplements: Effects in obesity and metabolic syndrome and relationship to gastrointestinal functions
    • e1 - e2
    • Papathanasopoulos A, Camilleri M,. Dietary fiber supplements: effects in obesity and metabolic syndrome and relationship to gastrointestinal functions. Gastroenterology. 2010; 138 (1): 65-72. e1-e2.
    • (2010) Gastroenterology , vol.138 , Issue.1 , pp. 65-72
    • Papathanasopoulos, A.1    Camilleri, M.2
  • 7
    • 84860630996 scopus 로고    scopus 로고
    • Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: A randomized, double-blind, cross-over investigation in obese persons
    • Andersson U, Berger K, Hogberg A, Landin-Olsson M, Holm C,. Effects of rose hip intake on risk markers of type 2 diabetes and cardiovascular disease: a randomized, double-blind, cross-over investigation in obese persons. Eur J Clin Nutr. 2012; 66 (5): 585-590.
    • (2012) Eur J Clin Nutr , vol.66 , Issue.5 , pp. 585-590
    • Andersson, U.1    Berger, K.2    Hogberg, A.3    Landin-Olsson, M.4    Holm, C.5
  • 8
    • 84893982496 scopus 로고    scopus 로고
    • Nutraceutical approach to moderate cardiometabolic risk: Results of a randomized, double-blind and crossover study with Armolipid Plus
    • Ruscica M, Gomaraschi M, Mombelli G,. Nutraceutical approach to moderate cardiometabolic risk: results of a randomized, double-blind and crossover study with Armolipid Plus. J Clin Lipidol. 2014; 8 (1): 61-68.
    • (2014) J Clin Lipidol , vol.8 , Issue.1 , pp. 61-68
    • Ruscica, M.1    Gomaraschi, M.2    Mombelli, G.3
  • 9
    • 84895784679 scopus 로고    scopus 로고
    • Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFalpha treatment
    • Skroza N, Proietti I, Bernardini N,. Efficacy of food supplement to improve metabolic syndrome parameters in patients affected by moderate to severe psoriasis during anti-TNFalpha treatment. G Ital Dermatol Venereol. 2013; 148 (6): 661-665.
    • (2013) G Ital Dermatol Venereol , vol.148 , Issue.6 , pp. 661-665
    • Skroza, N.1    Proietti, I.2    Bernardini, N.3
  • 10
    • 84927509540 scopus 로고    scopus 로고
    • Health benefits of the mediterranean diet: An update of research over the last 5 years
    • Gotsis E, Anagnostis P, Mariolis A, Vlachou A, Katsiki N, Karagiannis A,. Health benefits of the mediterranean diet: an update of research over the last 5 years. Angiology. 2015; 66 (4): 304-318.
    • (2015) Angiology , vol.66 , Issue.4 , pp. 304-318
    • Gotsis, E.1    Anagnostis, P.2    Mariolis, A.3    Vlachou, A.4    Katsiki, N.5    Karagiannis, A.6
  • 11
    • 84876439194 scopus 로고    scopus 로고
    • Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome?
    • Sahebkar A,. Why it is necessary to translate curcumin into clinical practice for the prevention and treatment of metabolic syndrome? Biofactors. 2013; 39 (2): 197-208.
    • (2013) Biofactors , vol.39 , Issue.2 , pp. 197-208
    • Sahebkar, A.1
  • 13
    • 58049202275 scopus 로고    scopus 로고
    • Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study
    • Nohr LA, Rasmussen LB, Straand J,. Resin from the mukul myrrh tree, guggul, can it be used for treating hypercholesterolemia? A randomized, controlled study. Complement Ther Med. 2009; 17 (1): 16-22.
    • (2009) Complement Ther Med , vol.17 , Issue.1 , pp. 16-22
    • Nohr, L.A.1    Rasmussen, L.B.2    Straand, J.3
  • 14
    • 29744435922 scopus 로고    scopus 로고
    • Guggul for hyperlipidemia: A review by the Natural Standard Research Collaboration
    • Ulbricht C, Basch E, Szapary P,. Guggul for hyperlipidemia: a review by the Natural Standard Research Collaboration. Complement Ther Med. 2005; 13 (4): 279-290.
    • (2005) Complement Ther Med , vol.13 , Issue.4 , pp. 279-290
    • Ulbricht, C.1    Basch, E.2    Szapary, P.3
  • 15
    • 0042160272 scopus 로고    scopus 로고
    • Guggulipid for the treatment of hypercholesterolemia: A randomized controlled trial
    • Szapary PO, Wolfe ML, Bloedon LT,. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003; 290 (6): 765-772.
    • (2003) JAMA , vol.290 , Issue.6 , pp. 765-772
    • Szapary, P.O.1    Wolfe, M.L.2    Bloedon, L.T.3
  • 16
    • 84877253133 scopus 로고    scopus 로고
    • Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice
    • Mubarak A, Hodgson JM, Considine MJ, Croft KD, Matthews VB,. Supplementation of a high-fat diet with chlorogenic acid is associated with insulin resistance and hepatic lipid accumulation in mice. J Agric Food Chem. 2013; 61 (18): 4371-4378.
    • (2013) J Agric Food Chem , vol.61 , Issue.18 , pp. 4371-4378
    • Mubarak, A.1    Hodgson, J.M.2    Considine, M.J.3    Croft, K.D.4    Matthews, V.B.5
  • 17
    • 0036903553 scopus 로고    scopus 로고
    • Chlorogenic acid modifies plasma and liver concentrations of: Cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats
    • Rodriguez de Sotillo DV, Hadley M,. Chlorogenic acid modifies plasma and liver concentrations of: cholesterol, triacylglycerol, and minerals in (fa/fa) Zucker rats. J Nutr Biochem. 2002; 13 (12): 717-726.
    • (2002) J Nutr Biochem , vol.13 , Issue.12 , pp. 717-726
    • Rodriguez De Sotillo, D.V.1    Hadley, M.2
  • 18
    • 0344435493 scopus 로고    scopus 로고
    • Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects
    • Ellegard L, Andersson H, Bosaeus I,. Inulin and oligofructose do not influence the absorption of cholesterol, or the excretion of cholesterol, Ca, Mg, Zn, Fe, or bile acids but increases energy excretion in ileostomy subjects. Eur J Clin Nutr. 1997; 51 (1): 1-5.
    • (1997) Eur J Clin Nutr , vol.51 , Issue.1 , pp. 1-5
    • Ellegard, L.1    Andersson, H.2    Bosaeus, I.3
  • 19
    • 27644519985 scopus 로고    scopus 로고
    • Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute
    • Grundy SM,. Metabolic syndrome scientific statement by the American Heart Association and the National Heart, Lung, and Blood Institute. Arterioscler Thromb Vasc Biol. 2005; 25 (11): 2243-2244.
    • (2005) Arterioscler Thromb Vasc Biol , vol.25 , Issue.11 , pp. 2243-2244
    • Grundy, S.M.1
  • 21
    • 84941843774 scopus 로고
    • Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency
    • Nagele U, Hagele EO, Sauer G,. Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem. 1984; 22 (2): 165-174.
    • (1984) J Clin Chem Clin Biochem , vol.22 , Issue.2 , pp. 165-174
    • Nagele, U.1    Hagele, E.O.2    Sauer, G.3
  • 22
    • 0022396983 scopus 로고
    • Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol
    • Warnick GR, Nguyen T, Albers AA,. Comparison of improved precipitation methods for quantification of high-density lipoprotein cholesterol. Clin Chem. 1985; 31 (2): 217-222.
    • (1985) Clin Chem , vol.31 , Issue.2 , pp. 217-222
    • Warnick, G.R.1    Nguyen, T.2    Albers, A.A.3
  • 23
    • 0028306066 scopus 로고
    • Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides
    • Simon PW,. Ferrous ion oxidation in presence of ferric ion indicator xylenol orange for measurement of hydroperoxides. Meth Enzymol. 1994; 233: 182-189.
    • (1994) Meth Enzymol , vol.233 , pp. 182-189
    • Simon, P.W.1
  • 24
    • 0028283301 scopus 로고
    • Measurement of protein thiol groups and glutathione in plasma
    • Hu ML,. Measurement of protein thiol groups and glutathione in plasma. Meth Enzymol. 1994; 233: 380-385. doi: 10.1016/S0076-6879(94)33021-2.
    • (1994) Meth Enzymol , vol.233 , pp. 380-385
    • Hu, M.L.1
  • 26
    • 76749122292 scopus 로고    scopus 로고
    • Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice
    • Cho AS, Jeon SM, Kim MJ,. Chlorogenic acid exhibits anti-obesity property and improves lipid metabolism in high-fat diet-induced-obese mice. Food Chem Toxicol. 2010; 48 (3): 937-943.
    • (2010) Food Chem Toxicol , vol.48 , Issue.3 , pp. 937-943
    • Cho, A.S.1    Jeon, S.M.2    Kim, M.J.3
  • 27
    • 33746451661 scopus 로고    scopus 로고
    • Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice
    • Shimoda H, Seki E, Aitani M,. Inhibitory effect of green coffee bean extract on fat accumulation and body weight gain in mice. BMC Complement Altern Med. 2006; 6: 9.
    • (2006) BMC Complement Altern Med , vol.6 , pp. 9
    • Shimoda, H.1    Seki, E.2    Aitani, M.3
  • 28
    • 0022844115 scopus 로고
    • Clinical trial of gugulipid - A new hypolipidemic agent of plant origin in primary hyperlipidemia
    • Agarwal RC, Singh SP, Saran RK,. Clinical trial of gugulipid - a new hypolipidemic agent of plant origin in primary hyperlipidemia. Indian J Med Res. 1986; 84: 626-634.
    • (1986) Indian J Med Res , vol.84 , pp. 626-634
    • Agarwal, R.C.1    Singh, S.P.2    Saran, R.K.3
  • 30
    • 0028073940 scopus 로고
    • Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia
    • Singh RB, Niaz MA, Ghosh S,. Hypolipidemic and antioxidant effects of Commiphora mukul as an adjunct to dietary therapy in patients with hypercholesterolemia. Cardiovasc Drugs Ther. 1994; 8 (4): 659-664.
    • (1994) Cardiovasc Drugs Ther , vol.8 , Issue.4 , pp. 659-664
    • Singh, R.B.1    Niaz, M.A.2    Ghosh, S.3
  • 31
    • 0017589706 scopus 로고
    • Long term clinical studies on the hypolipidaemic effect of Commiphora mukul (Guggulu) and clofibrate
    • Malhotra SC, Ahuja MM, Sundaram KR,. Long term clinical studies on the hypolipidaemic effect of Commiphora mukul (Guggulu) and clofibrate. Indian J Med Res. 1977; 65 (3): 390-395.
    • (1977) Indian J Med Res , vol.65 , Issue.3 , pp. 390-395
    • Malhotra, S.C.1    Ahuja, M.M.2    Sundaram, K.R.3
  • 32
    • 0842281422 scopus 로고    scopus 로고
    • The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL
    • Wang X, Greilberger J, Ledinski G, Kager G, Paigen B, Jurgens G,. The hypolipidemic natural product Commiphora mukul and its component guggulsterone inhibit oxidative modification of LDL. Atherosclerosis. 2004; 172 (2): 239-246.
    • (2004) Atherosclerosis , vol.172 , Issue.2 , pp. 239-246
    • Wang, X.1    Greilberger, J.2    Ledinski, G.3    Kager, G.4    Paigen, B.5    Jurgens, G.6
  • 33
    • 84857094415 scopus 로고    scopus 로고
    • Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects
    • Vinson JA, Burnham BR, Nagendran MV,. Randomized, double-blind, placebo-controlled, linear dose, crossover study to evaluate the efficacy and safety of a green coffee bean extract in overweight subjects. Diabetes Metab Syndr Obes. 2012; 5: 21-27.
    • (2012) Diabetes Metab Syndr Obes , vol.5 , pp. 21-27
    • Vinson, J.A.1    Burnham, B.R.2    Nagendran, M.V.3
  • 34
    • 84937937489 scopus 로고    scopus 로고
    • Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): A comparative study
    • Oboh G, Agunloye OM, Adefegha SA, Akinyemi AJ, Ademiluyi AO,. Caffeic and chlorogenic acids inhibit key enzymes linked to type 2 diabetes (in vitro): a comparative study. J Basic Clin Physiol Pharmacol. 2015; 26 (2): 165-170.
    • (2015) J Basic Clin Physiol Pharmacol , vol.26 , Issue.2 , pp. 165-170
    • Oboh, G.1    Agunloye, O.M.2    Adefegha, S.A.3    Akinyemi, A.J.4    Ademiluyi, A.O.5
  • 35
    • 80054020103 scopus 로고    scopus 로고
    • Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats
    • Tunnicliffe JM, Eller LK, Reimer RA, Hittel DS, Shearer J,. Chlorogenic acid differentially affects postprandial glucose and glucose-dependent insulinotropic polypeptide response in rats. Appl Physiol Nutr Metab. 2011; 36 (5): 650-659.
    • (2011) Appl Physiol Nutr Metab , vol.36 , Issue.5 , pp. 650-659
    • Tunnicliffe, J.M.1    Eller, L.K.2    Reimer, R.A.3    Hittel, D.S.4    Shearer, J.5
  • 36
    • 84873196529 scopus 로고    scopus 로고
    • Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of "curcumin with piperine and quercetin"
    • Kaur GCM,. Amelioration of obesity, glucose intolerance, and oxidative stress in high-fat diet and low-dose streptozotocin-induced diabetic rats by combination consisting of "curcumin with piperine and quercetin". ISRN Pharmacol. 2012; 2012: 957283.
    • (2012) ISRN Pharmacol , vol.2012 , pp. 957283
    • Kaur, G.C.M.1
  • 37
    • 84874777446 scopus 로고    scopus 로고
    • Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy
    • Aziz MT, El Ibrashy IN, Mikhailidis DP,. Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. Diabetol Metab Syndr. 2013; 5 (1): 13.
    • (2013) Diabetol Metab Syndr , vol.5 , Issue.1 , pp. 13
    • Aziz, M.T.1    El Ibrashy, I.N.2    Mikhailidis, D.P.3
  • 38
    • 33845618025 scopus 로고    scopus 로고
    • The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: A randomized, double-blind, placebo-controlled, clinical trial
    • Huseini HF, Larijani B, Heshmat R,. The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother Res. 2006; 20 (12): 1036-1039.
    • (2006) Phytother Res , vol.20 , Issue.12 , pp. 1036-1039
    • Huseini, H.F.1    Larijani, B.2    Heshmat, R.3
  • 39
    • 84872355630 scopus 로고    scopus 로고
    • Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control
    • Di Pierro F, Villanova N, Agostini F, Marzocchi R, Soverini V, Marchesini G,. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control. Diabetes Metab Syndr Obes. 2012; 5: 213-217.
    • (2012) Diabetes Metab Syndr Obes , vol.5 , pp. 213-217
    • Di Pierro, F.1    Villanova, N.2    Agostini, F.3    Marzocchi, R.4    Soverini, V.5    Marchesini, G.6
  • 40
    • 84887887852 scopus 로고    scopus 로고
    • Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes
    • Di Pierro F, Putignano P, Villanova N, Montesi L, Moscatiello S, Marchesini G,. Preliminary study about the possible glycemic clinical advantage in using a fixed combination of Berberis aristata and Silybum marianum standardized extracts versus only Berberis aristata in patients with type 2 diabetes. Clin Pharmacol. 2013; 5: 167-174.
    • (2013) Clin Pharmacol , vol.5 , pp. 167-174
    • Di Pierro, F.1    Putignano, P.2    Villanova, N.3    Montesi, L.4    Moscatiello, S.5    Marchesini, G.6
  • 41
    • 77950199410 scopus 로고    scopus 로고
    • Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers
    • Russo F, Riezzo G, Chiloiro M,. Metabolic effects of a diet with inulin-enriched pasta in healthy young volunteers. Curr Pharm Des. 2010; 16 (7): 825-831.
    • (2010) Curr Pharm des , vol.16 , Issue.7 , pp. 825-831
    • Russo, F.1    Riezzo, G.2    Chiloiro, M.3
  • 42
    • 45849110636 scopus 로고    scopus 로고
    • Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet
    • Sugatani J, Osabe M, Wada T,. Comparison of enzymatically synthesized inulin, resistant maltodextrin and clofibrate effects on biomarkers of metabolic disease in rats fed a high-fat and high-sucrose (cafeteria) diet. Eur J Nutr. 2008; 47 (4): 192-200.
    • (2008) Eur J Nutr , vol.47 , Issue.4 , pp. 192-200
    • Sugatani, J.1    Osabe, M.2    Wada, T.3
  • 43
    • 23744510724 scopus 로고    scopus 로고
    • Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia
    • Osawa T, Kato Y,. Protective role of antioxidative food factors in oxidative stress caused by hyperglycemia. Ann N Y Acad Sci. 2005; 1043: 440-451.
    • (2005) Ann N y Acad Sci , vol.1043 , pp. 440-451
    • Osawa, T.1    Kato, Y.2
  • 44
    • 77955269962 scopus 로고    scopus 로고
    • Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes - An in vitro study
    • Kiruthiga PV, Pandian SK, Devi KP,. Silymarin protects PBMC against B(a)P induced toxicity by replenishing redox status and modulating glutathione metabolizing enzymes - an in vitro study. Toxicol Appl Pharmacol. 2010; 247 (2): 116-128.
    • (2010) Toxicol Appl Pharmacol , vol.247 , Issue.2 , pp. 116-128
    • Kiruthiga, P.V.1    Pandian, S.K.2    Devi, K.P.3
  • 45
    • 84895067588 scopus 로고    scopus 로고
    • Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes
    • Bouderba S, Sanchez-Martin C, Villanueva GR, Detaille D, Koceir EA,. Beneficial effects of silibinin against the progression of metabolic syndrome, increased oxidative stress, and liver steatosis in Psammomys obesus, a relevant animal model of human obesity and diabetes. J Diabetes. 2014; 6 (2): 184-192.
    • (2014) J Diabetes , vol.6 , Issue.2 , pp. 184-192
    • Bouderba, S.1    Sanchez-Martin, C.2    Villanueva, G.R.3    Detaille, D.4    Koceir, E.A.5
  • 46
    • 80051769525 scopus 로고    scopus 로고
    • "european panel on low density lipoprotein (LDL) subclasses": A statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: Executive summary
    • Mikhailidis DP, Elisaf M, Rizzo M,. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses: executive summary. Curr Vasc Pharmacol. 2011; 9 (5): 531-532.
    • (2011) Curr Vasc Pharmacol , vol.9 , Issue.5 , pp. 531-532
    • Mikhailidis, D.P.1    Elisaf, M.2    Rizzo, M.3
  • 47
    • 80051725784 scopus 로고    scopus 로고
    • "european panel on low density lipoprotein (LDL) subclasses": A statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses
    • Mikhailidis DP, Elisaf M, Rizzo M,. "European panel on low density lipoprotein (LDL) subclasses": a statement on the pathophysiology, atherogenicity and clinical significance of LDL subclasses. Curr Vasc Pharmacol. 2011; 9 (5): 533-571.
    • (2011) Curr Vasc Pharmacol , vol.9 , Issue.5 , pp. 533-571
    • Mikhailidis, D.P.1    Elisaf, M.2    Rizzo, M.3
  • 48


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.